These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 657746)
1. [Hepatotropic action of calcium 2,2'-disulfohexanoate]. Ferrari B; Della Seta L; Boscaini M; Piccini Leopardi M Clin Ter; 1978 Apr; 85(2):163-72. PubMed ID: 657746 [No Abstract] [Full Text] [Related]
2. [Clinical evaluation of the activity of calcium-2,2'-disulfohexanoate in liver insufficiency]. Romboli L; Leonardi R; Bertucci P; Fortunati P Clin Ter; 1978 Nov; 87(3):265-72. PubMed ID: 753574 [No Abstract] [Full Text] [Related]
3. [Use of calcium 2,2'-disulfohexanoate in chronic hepatopathies]. Ortolan A; Martin A; Pieropan G Minerva Dietol Gastroenterol; 1978; 24(1):7-11. PubMed ID: 740272 [No Abstract] [Full Text] [Related]
4. [Calcium-2,2'-disulfohexanoate in the treatment of liver diseases: study of a series of 15 patients]. Piludu G; Perpignano G Clin Ter; 1981 May; 97(4):377-82. PubMed ID: 7249568 [No Abstract] [Full Text] [Related]
5. [Treatment of acute and chronic liver diseases with calcium-2,2'-disulfohexanoate]. Ravetta A Clin Ter; 1979 Aug; 90(4):357-68. PubMed ID: 262631 [No Abstract] [Full Text] [Related]
6. [Therapeutic effects of calcium-2,2'-disulfohexanoate in hepatic cirrhosis]. Cangiano C; Angelico M; Rossi Fanelli F Clin Ter; 1978 Aug; 86(4):337-53. PubMed ID: 737963 [No Abstract] [Full Text] [Related]
7. [Changes in some blood chemical parameters in patients with chronic liver diseases treated with calcium-2,2'-disulfohexanoate]. Turpini R; Scotti A; Brusoni V; Perego M Clin Ter; 1980 Jun; 93(6):689-94. PubMed ID: 7428323 [No Abstract] [Full Text] [Related]
8. [Controlled double-blind study of the effects of cycloxilic acid on hepato-biliary function]. Rosselli M; Cavrini P Clin Ter; 1978 Sep; 86(5):465-84. PubMed ID: 367682 [No Abstract] [Full Text] [Related]
9. [Action of calcium 2,2'-disulfohexanoate on the course of acute viral hepatitis: double-blind study]. Calonghi G; Sueri L Clin Ter; 1982 Nov; 103(3):273-82. PubMed ID: 6759010 [No Abstract] [Full Text] [Related]
10. [Evaluation of therapeutic activity of a new pharmacologic combination in patients with chronic liver and debilitating diseases]. Pasotti C; Buniva G; Carpinella G Clin Ter; 1971 Mar; 56(5):427-39. PubMed ID: 5564990 [No Abstract] [Full Text] [Related]
12. [Clinical observations on a new preparation with hepatoprotective action]. Fanelli V Clin Ter; 1967 Jan; 40(2):145-56. PubMed ID: 4234340 [No Abstract] [Full Text] [Related]
13. [Clinical research and methodological study of an eupeptic-hepatotropic combination]. Magnati G; Strata A; Tirelli F Clin Ter; 1975 Jul; 74(2):135-44. PubMed ID: 770056 [No Abstract] [Full Text] [Related]
14. [A contribution to the therapy of dyspeptic disorders]. Alker C Med Monatsschr; 1969 May; 23(5):234-7. PubMed ID: 5801882 [No Abstract] [Full Text] [Related]
15. [The effect of Ora-Gallin in digestive insufficiency]. Dierel HL Wien Med Wochenschr; 1967 Jul; 117(27):698-701. PubMed ID: 5598254 [No Abstract] [Full Text] [Related]
16. [Therapeutic results in non-specific intestinal disorders using Mexase]. Zawodsky L Wien Med Wochenschr; 1969 Feb; 119(5):94-8. PubMed ID: 4239538 [No Abstract] [Full Text] [Related]
17. The extrapolation of liver function data from the animal to the human in the treatment of the acute stage of liver damage with the hepatotropic factor. Timar M Farmaco Prat; 1976 Sep; 31(9):473-8. PubMed ID: 1010021 [No Abstract] [Full Text] [Related]
18. [Symptomatic treatment of dyspepsia in patients with digestive system diseases]. Tkachev AV Eksp Klin Gastroenterol; 2006; (6):56-60. PubMed ID: 17612097 [No Abstract] [Full Text] [Related]
19. [Treatment of gastroduodenal ulcers through the combination calcium acexamate-light bismuth nitrate]. Hureau J; Bourdais JP Med Chir Dig; 1973; 2(4):xxxi-xxxiv. PubMed ID: 4612265 [No Abstract] [Full Text] [Related]